Novartis Needs Board Shakeup and M&A Revamp, Investor Says

Novartis AG shareholder Artisan Partners said the Swiss drugmaker needs to shake up its board and improve dealmaking after its shares plunged following three major clinical trial setbacks, Reuters reported.